Five things explain almost all of it, and the first is the least satisfying: the fast stretch was never going to last. Weight loss on these medications is front-loaded, and the steepest months are the first ones. What feels like stopping is often the expected shape of the curve arriving on schedule. The other four explanations are a dose that was never completed, a body that now needs less, eating that has drifted back, and a medication that may not be delivering what it should.<\/p>\n
That last one is worth reading even though nobody suspects it, because it is checkable and it is invisible.<\/p>\n
The first months are the fastest, and the rate moderates afterward even when nothing goes wrong. A large part of the early drop is also fluid and digestive changes rather than fat, which front-loads the number further.<\/p>\n
The way to test this: compare against the four to six weeks before things stopped, not against your best month. If the rate was already easing before it flattened, you are looking at a curve rather than a wall.<\/p>\n
Three months is roughly where people are still climbing. If you paused escalation because things were going well, because of side effects, or because an appointment slipped, you may be sitting at an intermediate dose that produces intermediate results.<\/p>\n
This explains a lot of three-month stalls and it is the easiest to fix. Our guide on when to increase your tirzepatide dose<\/a> covers the signals your provider weighs.<\/p>\n A smaller body uses less energy. The gap between what you eat and what you use narrows as you lose, even with the medication and your eating unchanged.<\/p>\n This is arithmetic rather than failure, and it is the reason a plan that worked at your starting weight may need revisiting three months in.<\/p>\n Portions creep back as appetite suppression becomes normal. Nobody decides to do this; it is what happens when a constraint stops being novel. A related version: the early nausea that made rich or fried food unappealing settles, and those foods come back without any deliberate choice.<\/p>\n Worth looking at two weeks of actual eating rather than a typical day, and at protein specifically.<\/p>\n The one nobody checks.<\/p>\n Tirzepatide is a peptide. Heat, freezing, and agitation cause peptide molecules to unfold and aggregate, and aggregated peptide has reduced or absent activity. This happens invisibly, before anything looks cloudy. Research on how temperature-sensitive medications actually fare in domestic refrigerators has repeatedly found conditions outside the recommended range, including freezing against the rear wall.<\/p>\n Worth checking if your stall lines up with any of: a house move, a new or failing refrigerator, a delivery that arrived warm, a holiday where the medication travelled, or a change of pharmacy or preparation. Our guide to storing compounded semaglutide or tirzepatide at home<\/a> covers what good storage looks like, including why a minimum-maximum thermometer is worth the small cost.<\/p>\nExplanation 3: your body needs less than it did<\/h2>\n
Explanation 4: eating has drifted<\/h2>\n
Explanation 5: the medication may not be delivering<\/h2>\n